OFFICIAL PUBLICATION OF

by its subsidiary APPco

New once-daily Hep C treatment recommended for PBS

Megan Haggan 23/01/2017

liver cancer: "liver" spelled out on post-its hanging from line

The first and only one-tablet, once-a-day treatment for all genotypes of chronic hepatitis C infection has been recommended for PBS listing Gilead Sciences Australia has announced that the TGA has registered a new treatment for the treatment of chronic hepatitis C infection in adults. The PBAC has also recommended EPCLUSA (sofosbuvir/velpatasvir) for listing on the

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

‘Category killer’ CWH has scope for growth

Easier said than done. I agree with you, but you know how hard it is too.

D vL

‘Category killer’ CWH has scope for growth

You're under no obligation to provide advice on that product. In fact, you probably shouldn't because you have not screened…

Bart Pharm

Did wave of protest fail to break?

Are they? STILL SOLICITING BRIBES!

D vL

Did wave of protest fail to break?

Coles and Woolies have been good for competition? Have you not followed the Senate inquiry into the supermarkets and how…

Bart Pharm

New once-daily Hep C treatment recommended for PBS

Previous APP2017 welcomes back Malcolm Scrymgeour

Next The reason behind skyrocketing autism rates

Clinical tips: Timing!

Clinical tips: Movement disorders

Clinical tips: Worms, Worms, Worms

Intranasal Midazolam for at home use

MENU

Previous APP2017 welcomes back Malcolm Scrymgeour

Next The reason behind skyrocketing autism rates

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.